Investor Alert

New York Markets Close in:

Market Pulse Archives

Dec. 3, 2021, 8:35 a.m. EST

GTCR portfolio company Resonetics valued at $2.25 billion in minority stake sale to Carlyle

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Carlyle Group Inc. (CG)

or Cancel Already have a watchlist? Log In

By Steve Gelsi


Private equity firms GTCR and Sverica Capital Management said Friday they sold a minority equity stake in portfolio company, Resonetics to funds affiliated with Carlyle /zigman2/quotes/200142014/composite CG +1.03% in a deal that values the Nashua, N.H., medical micro-device manufacturer at about $2.25 billion. The firms did not disclose the dollar amount of the minority investment. Carlyle will join GTCR as a "meaningful shareholder" in Resonetics, the firms said. GTCR made its initial investment in Resonetics in 2018 in partnership with medical technology industry executive Robert "Chip" Hance. GTCR teamed up with Hance to form Regatta Medical in April 2017 to pursue opportunities in the medical device sector. In 2018, Regatta Medical announced a recapitalization transaction with Resonetics, for an undisclosed price. Sverica Capital management invested in Resonetics in 2014 and will retain a minority stake in the company.

US : U.S.: Nasdaq
$ 46.98
+0.48 +1.03%
Volume: 1.41M
Jan. 27, 2022 3:19p
P/E Ratio
Dividend Yield
Market Cap
$16.58 billion
Rev. per Employee

Get news alerts on Carlyle Group Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.